Borrow it
Coverart for item
The Resource Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou

Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou

Creator
Author
Summary
  • "The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
  • "The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
Language
eng
Work
Publication
Edition
First Edition.
Extent
x, 339 pages
Isbn
9781524731656
Instance
Label
Bad blood : secrets and lies in a Silicon Valley startup
Title
Bad blood
Title remainder
secrets and lies in a Silicon Valley startup
Statement of responsibility
John Carreyrou
Creator
Author
Subject
Language
eng
Summary
  • "The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
  • "The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
Assigning source
  • Provided by publisher
  • Provided by publisher
Cataloging source
DLC
http://library.link/vocab/creatorName
Carreyrou, John
Dewey number
338.7/681761
Index
no index present
LC call number
HD9995.H423
LC item number
U627 2018
Literary form
non fiction
http://library.link/vocab/subjectName
  • Theranos (Firm)
  • Hematologic equipment industry
  • Fraud
Label
Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou
Instantiates
Publication
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
sky292439769
Dimensions
25 cm
Edition
First Edition.
Extent
x, 339 pages
Isbn
9781524731656
Isbn Type
(hardback)
Lccn
2018000263
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Note
mv 05/18, jtv 08/18; mv 08/18
Label
Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou
Publication
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
sky292439769
Dimensions
25 cm
Edition
First Edition.
Extent
x, 339 pages
Isbn
9781524731656
Isbn Type
(hardback)
Lccn
2018000263
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Note
mv 05/18, jtv 08/18; mv 08/18

Subject

Included in

Library Locations

    • KDL Byron Twp. BranchBorrow it
      8191 Byron Center Ave. SW, Byron Center, MI, 49315, US
      42.8164386 -85.7240006
    • KDL Cascade Twp. BranchBorrow it
      2870 Jacksmith Ave. SE, Grand Rapids, MI, 49546, US
      42.9117597 -85.5043438
    • KDL East Grand Rapids BranchBorrow it
      746 Lakeside Dr. SE, East Grand Rapids, MI, 49506, US
      42.9494868 -85.6117855
    • KDL Kentwood (Richard L. Root) BranchBorrow it
      4950 Breton SE, Kentwood, MI, 49508, US
      42.8734607 -85.5964298

Library Links

Structured data from the Bibframe namespace is licensed under the Creative Commons Attribution 4.0 International License by Kent District Library. Additional terms may apply to data associated with third party namespaces.
Processing Feedback ...